Aberrant expression of NLRP3, NLRC4 and NLRP6 inflammasomes in patients with primary immune thrombocytopenia
- 1 April 2019
- journal article
- letter
- Published by Elsevier in Thrombosis Research
- Vol. 176, 101-103
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (91846103, 81871709)
- Natural Science Foundation of Zhejiang Province (LY16H200001, LY13H080001)
- Scientific Research Projects of Education of Zhejiang Province of China (Y201839408, Y201635928)
This publication has 10 references indexed in Scilit:
- Emerging Concepts in Immune ThrombocytopeniaFrontiers in Immunology, 2018
- Elevated expression of NLRP3 in patients with immune thrombocytopeniaImmunologic Research, 2015
- Changes in Follicular Helper T Cells in Idiopathic Thrombocytopenic Purpura PatientsInternational Journal of Biological Sciences, 2015
- Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in FranceBlood, 2014
- Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopeniaBlood, 2014
- Diagnosis and classification of immune-mediated thrombocytopeniaAutoimmunity Reviews, 2014
- The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopeniaHaematologica, 2011
- The Inflammasome NLRs in Immunity, Inflammation, and Associated DiseasesAnnual Review of Immunology, 2011
- Immune Thrombocytopenic PurpuraNew England Journal of Medicine, 2002
- Evaluation of a solid phase red cell adherence technique for platelet antibody screeningTransfusion Medicine, 1991